Diversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Simpalipan, Phumin ^a   Pattaradilokrat, Sittiporn ^a   Siripoon, Napaporn ^a   Seugorn, Aree ^a   Kaewthamasorn, Morakot ^a   Butcher, Robert Dj ^a   Harnyuttanakorn, Pongchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Allelic polymorphism; DNA sequencing; Merozoite surface antigen; Population structure; Southeast Asia

Indexed keywords

MEROZOITE SURFACE PROTEIN 1;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CAMBODIA; CARBOXY TERMINAL SEQUENCE; GENE FLOW; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LAOS; MALARIA; MICROBIAL DIVERSITY; MYANMAR; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; POPULATION STRUCTURE; PROTEIN DOMAIN; SEASON; THAILAND;

CAMBODIA; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LAOS; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MYANMAR; PHYLOGEOGRAPHY; PLASMODIUM FALCIPARUM; SEQUENCE ANALYSIS, DNA; THAILAND; TIME;

EID: 84896726375     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-54     Document Type: Article

References (76)

1. The pathogenic basis of malaria. Miller LH, Baruch DI, Marsh K, Doumbo OK, Nature 2002 415 673 679 10.1038/415673a 11832955 (Pubitemid 34136400)
2. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. Cowman AF, Berry D, Baum J, J Cell Biol 2012 198 961 971 10.1083/jcb.201206112 22986493
3. Malaria biology and disease pathogenesis: insights for new treatments. Miller LH, Ackerman HC, Su XZ, Wellems TE, Nat Med 2013 19 156 167 10.1038/nm.3073 23389616
4. Malaria vaccines and their potential role in the elimination of malaria. Targett GA, Greenwood BM, Malar J 2008 7 10 10.1186/1475-2875-7-S1-S10 19091034
5. WHO, World Malaria Report 2012. World Health Organization Geneva http://www.who.int/malaria/publications/world-malaria-report-2012/report/en/ index.html
6. Malaria drug resistance: new observations and developments. Sa JM, Chong JL, Wellems TE, Essays Biochem 2011 51 137 160 22023447
7. Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Ellis RD, Sagara I, Doumbo O, Wu Y, Hum Vaccin 2010 6 627 634 10.4161/hv.6.8.11446 20519960
8. Blood-stage malaria vaccines-recent progress and future challenges. Goodman AL, Draper SJ, Ann Trop Med Parasitol 2010 104 189 211 10.1179/136485910X12647085215534 20507694
9. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP, J Infect Dis 2002 185 820 827 10.1086/339342 11920300 (Pubitemid 34226210)
10. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Good MF, Stanisic D, Xu H, Elliott S, Wykes M, Immunol Rev 2004 201 254 267 10.1111/j.0105-2896.2004.00178.x 15361246 (Pubitemid 39318457)
11. Asexual blood-stage malaria vaccine development: facing the challenges. Genton B, Reed ZH, Curr Opin Infect Dis 2007 20 467 475 10.1097/QCO. 0b013e3282dd7a29 17762779 (Pubitemid 47359642)
12. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ, Parassitologia 1999 41 409 414 10697894 (Pubitemid 129640287)
13. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. Holder AA, Parasitology 2009 136 1445 1456 10.1017/S0031182009990515 19627632
14. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Miller LH, Roberts T, Shahabuddin M, McCutchan TF, Mol Biochem Parasitol 1993 59 1 14 10.1016/0166-6851(93)90002-F 8515771
15. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. Tanabe K, Mackay M, Goman M, Scaife JG, J Mol Biol 1987 195 273 287 10.1016/0022-2836(87)90649-8 3079521 (Pubitemid 17106691)
16. Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Peterson MG, Coppel RL, Moloney MB, Kemp DJ, Mol Cell Biol 1988 8 2664 2667 3043189
17. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. McBride JS, Heidrich HG, Mol Biochem Parasitol 1987 23 71 84 10.1016/0166-6851(87)90189-7 2437453 (Pubitemid 17034743)
18. Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum. Hall R, Osland A, Hyde JE, Simmons DL, Hope IA, Scaife JG, Mol Biochem Parasitol 1984 11 61 80 6205267 (Pubitemid 14082581)
19. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Holder AA, Sandhu JS, Hillman Y, Davey LS, Nicholls SC, Cooper H, Lockyer MJ, Parasitology 1987 94 199 208 10.1017/S0031182000053889 3295686 (Pubitemid 17043460)
20. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA, J Exp Med 1990 172 379 382 10.1084/jem.172.1.379 1694225 (Pubitemid 20217284)
21. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Blackman MJ, Ling IT, Nicholls SC, Holder AA, Mol Biochem Parasitol 1991 49 29 33 10.1016/0166-6851(91)90127-R 1775158
22. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N, Bojang KA, Oduola AM, Kremsner PG, Arnot DE, Greenwood BM, McBride JS, Nat Med 2000 6 689 692 10.1038/76272 10835687 (Pubitemid 30398794)
23. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Polley SD, Tetteh KK, Cavanagh DR, Pearce RJ, Lloyd JM, Bojang KA, Okenu DM, Greenwood BM, McBride JS, Conway DJ, Infect Immun 2003 71 1833 1842 10.1128/IAI.71.4.1833-1842.2003 12654798 (Pubitemid 36368713)
24. Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JA, Theander TG, Akanmori BD, Polley S, Conway DJ, Koram K, McBride JS, Infect Immun 2004 72 6492 6502 10.1128/IAI.72.11.6492-6502.2004 15501780 (Pubitemid 39425430)
25. The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. Nwuba RI, Sodeinde O, Anumudu CI, Omosun YO, Odaibo AB, Holder AA, Nwagwu M, Infect Immun 2002 70 5328 5331 10.1128/IAI.70.9.5328-5331. 2002 12183594
26. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: Associations with febrile illness, parasitemia, and anemia. Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, Bloland PB, Kaslow DC, Lal AA, Am J Trop Med Hyg 1998 58 211 219 9502606 (Pubitemid 28096229)
27. Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: Subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay Cohort Project. Branch OH, Oloo AJ, Nahlen BL, Kaslow D, Lal AA, J Infect Dis 2000 181 1746 1752 10.1086/315424 10823777 (Pubitemid 30387769)
28. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow DC, Holder AA, Riley EM, J Infect Dis 1996 173 765 769 10.1093/infdis/173.3.765 8627050 (Pubitemid 26069671)
29. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1(19)) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. John CC, O'Donnell RA, Sumba PO, Moormann AM, de Koning-Ward TF, King CL, Kazura JW, Crabb BS, J Immunol 2004 173 666 672 15210830 (Pubitemid 38797397)
30. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Okech BA, Corran PH, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang TG, Holder AA, Riley EM, Infect Immun 2004 72 1557 1567 10.1128/IAI.72.3.1557-1567.2004 14977962 (Pubitemid 38263778)
31. The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in the Gambia. Corran PH, O'Donnell RA, Todd J, Uthaipibull C, Holder AA, Crabb BS, Riley EM, Infect Immun 2004 72 6185 6189 10.1128/IAI.72.10.6185-6189.2004 15385530 (Pubitemid 39303741)
32. Antibody specificities of children living in a malaria endemic area to inhibitory and blocking epitopes on MSP-1(19) of Plasmodium falciparum. Omosun YO, Adoro S, Anumudu CI, Odaibo AB, Uthiapibull C, Holder AA, Nwagwu M, Nwuba RI, Acta Trop 2009 109 208 212 10.1016/j.actatropica.2008.11.011 19081386
33. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. Perraut R, Marrama L, Diouf B, Sokhna C, Tall A, Nabeth P, Trape JF, Trape FO, Longacre S, Mercereau-Puijalon O, J Infect Dis 2005 191 264 271 10.1086/426398 15609237 (Pubitemid 40096385)
34. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers No protection to young children in western kenya. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR, MSP-1 Malaria Vaccine Working Group, PLoS One 2009 4 4708 10.1371/journal.pone.0004708 19262754
35. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1 (III) chimeric vaccine candidate with Montanide ISA720 adjuvant. Xue XY, Ding F, Zhang QF, Pan XG, Qu L, Pan WQ, Vaccine 2010 28 3152 3158 10.1016/j.vaccine.2010.02. 054 20197139
36. Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults. Hu J, Chen Z, Gu J, Wan M, Shen Q, Kieny MP, He J, Li Z, Zhang Q, Reed ZH, Zhu Y, Li W, Cao Y, Qu L, Cao Z, Wang Q, Liu H, Pan X, Huang X, Zhang D, Xue X, Pan W, PLoS One 2008 3 1952 10.1371/journal.pone.0001952 18398475 (Pubitemid 351984395)
37. Plasmodium falciparum: allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam. Kaneko O, Kimura M, Kawamoto F, Ferreira MU, Tanabe K, Exp Parasitol 1997 86 45 57 10.1006/expr.1997.4147 9149240 (Pubitemid 27224200)
38. Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite. Sakihama N, Kimura M, Hirayama K, Kanda T, Na-Bangchang K, Jongwutiwes S, Conway D, Tanabe K, Gene 1999 230 47 54 10.1016/S0378-1119(99)00069-4 10196473 (Pubitemid 29193194)
39. Allelic diversity in the merozoite surface protein 1 gene of Plasmodium falciparum on Palawan Island, the Philippines. Sakihama N, Nakamura M, Palanca AA Jr, Argubano RA, Realon EP, Larracas AL, Espina RL, Tanabe K, Parasitol Int 2007 56 185 194 10.1016/j.parint.2007.01.011 17347029 (Pubitemid 46970830)
40. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates. Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND, Exp Parasitol 2008 118 378 385 10.1016/j.exppara.2007. 10.001 18053992 (Pubitemid 351174153)
41. Sequence diversity and linkage disequilibrium within the merozoite surface protein-1 (Msp-1) locus of Plasmodium falciparum: a longitudinal study in Brazil. Da Silveira LA, Ribeiro WL, Kirchgatter K, Wunderlich G, Matsuoka H, Tanabe K, Ferreira MU, J Eukaryot Microbiol 2001 48 433 439 10.1111/j.1550-7408. 2001.tb00176.x 11456319 (Pubitemid 32646455)
42. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Qari SH, Shi YP, Goldman IF, Nahlen BL, Tibayrenc M, Lal AA, Mol Biochem Parasitol 1998 92 241 252 10.1016/S0166-6851(98)00010-3 9657329 (Pubitemid 28248098)
43. High frequency of recombination-driven allelic diversity and temporal variation of Plasmodium falciparum msp1 in Tanzania. Tanabe K, Sakihama N, Rooth I, Bjorkman A, Farnert A, Am J Trop Med Hyg 2007 76 1037 1045 17556608 (Pubitemid 351837863)
44. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. Takala SL, Coulibaly D, Thera MA, Dicko A, Smith DL, Guindo AB, Kone AK, Traore K, Ouattara A, Djimde AA, Sehdev PS, Lyke KE, Diallo DA, Doumbo OK, Plowe CV, PLoS Med 2007 4 93 10.1371/journal.pmed.0040093 17355170 (Pubitemid 46495320)
45. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Chenet SM, Branch OH, Escalante AA, Lucas CM, Bacon DJ, Malaria J 2008 7 93 10.1186/1475-2875-7-93 (Pubitemid 351862287)
46. Diversity and prevalence of the C-terminal region of Plasmodium falciparum merozoite surface protein 1 in China. Pan D, Hu J, Ma Q, Pan W, Li M, Acta Trop 2010 116 200 205 10.1016/j.actatropica.2010.08.004 20709011
47. Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Kang Y, Long CA, Mol Biochem Parasitol 1995 73 103 110 10.1016/0166-6851(95) 00102-7 8577318
48. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Sakihama N, Ohmae H, Bakote'e B, Kawabata M, Hirayama K, Tanabe K, Am J Trop Med Hyg 2006 74 31 40 16407343 (Pubitemid 46768627)
49. Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum. Ferreira MU, Ribeiro WL, Tonon AP, Kawamoto F, Rich SM, Gene 2003 304 65 75 12568716 (Pubitemid 36142063)
50. Plasmodium falciparum: genetic diversity of C-terminal region of MSP-1 in isolates from Indian sub-continent. Vijay Kumar S, Ranjan S, Saxena V, Rajesh V, Roy SK, Kochar D, Ranjan A, Das A, Exp Parasitol 2005 110 384 388 10.1016/j.exppara.2005.03.027 15907839 (Pubitemid 40805399)
51. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates. Jongwutiwes S, Tanabe K, Kanbara H, Mol Biochem Parasitol 1993 59 95 100 10.1016/0166-6851(93)90010-U 8515786
52. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, O'Brien J, Djimde A, Doumbo O, Zongo I, Ouedraogo JB, Michon P, Mueller I, Siba P, Nzila A, Borrmann S, Kiara SM, Marsh K, Jiang H, Su XZ, Amaratunga C, Fairhurst R, Socheat D, Nosten F, Imwong M, White NJ, Sanders M, Anastasi E, Alcock D, Drury E, et al. Nature 2012 487 375 379 10.1038/nature11174 22722859
53. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Mu J, Myers RA, Jiang H, Liu S, Ricklefs S, Waisberg M, Chotivanich K, Wilairatana P, Krudsood S, White NJ, Udomsangpetch R, Cui L, Ho M, Ou F, Li H, Song J, Li G, Wang X, Seila S, Sokunthea S, Socheat D, Sturdevant DE, Porcella SF, Fairhurst RM, Wellems TE, Awadalla P, Su XZ, Nat Genet 2010 42 268 271 10.1038/ng.528 20101240
54. [Malaria situation in the People's Republic of China in 2011]. Xia ZG, Yang MN, Zhou SS, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012 30 419 422 23484249
55. Artemisinin resistance: current status and scenarios for containment. Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, von Seidlein L, Nat Rev Microbiol 2010 8 272 280 20208550
56. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Fairhurst RM, Nayyar GM, Breman JG, Hallett R, Vennerstrom JL, Duong S, Ringwald P, Wellems TE, Plowe CV, Dondorp AM, Am J Trop Med Hyg 2012 87 231 241 10.4269/ajtmh.2012.12-0025 22855752
57. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, Artemisinin Resistance in Cambodia 1 Study C, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
58. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966 10.1016/S0140-6736(12)60484-X 22484134
59. Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country. Pumpaibool T, Arnathau C, Durand P, Kanchanakhan N, Siripoon N, Suegorn A, Sitthi-Amorn C, Renaud F, Harnyuttanakorn P, Malaria J 2009 8 155 10.1186/1475-2875-8-155
60. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 58 283 292 10.1016/0166-6851(93)90050-8 8479452
61. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Brown KN, Thaithong S, Do Rosario VE, Pinheiro L, Jarra W, Zhu XP, Viriyakosol S, Snounou G, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
62. Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Hall N, Pain A, Berriman M, Churcher C, Harris B, Harris D, Mungall K, Bowman S, Atkin R, Baker S, Barron A, Brooks K, Buckee CO, Burrows C, Cherevach I, Chillingworth C, Chillingworth T, Christodoulou Z, Clark L, Clark R, Corton C, Cronin A, Davies R, Davis P, Dear P, Dearden F, Doggett J, Feltwell T, Goble A, Goodhead I, et al. Nature 2002 419 527 531 10.1038/nature01095 12368867
63. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S, Mol Biol Evol 2011 28 2731 2739 10.1093/molbev/msr121 21546353
64. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Excoffier L, Lischer HE, Mol Ecol Resour 2010 10 564 567 10.1111/j.1755-0998.2010.02847.x 21565059
65. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Librado P, Rozas J, Bioinformatics 2009 25 1451 1452 10.1093/bioinformatics/ btp187 19346325
66. Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand. Paul RE, Hackford I, Brockman A, Muller-Graf C, Price R, Luxemburger C, White NJ, Nosten F, Day KP, Am J Trop Med Hyg 1998 58 195 203 9502604 (Pubitemid 28096227)
67. Epidemiology of Malaria in Thailand. Thimasarn K, Jatapadma S, Vijaykadga S, Sirichaisinthop J, Wongsrichanalai C, J Travel Med 1995 2 59 65 10.1111/j.1708-8305.1995.tb00627.x 9815363
68. Spatio-temporal distribution of Plasmodium falciparum and P. vivax malaria in Thailand. Zhou G, Sirichaisinthop J, Sattabongkot J, Jones J, Bjørnstad ON, Yan G, Cui L, Am J Trop Med Hyg 2005 72 256 62 15772317 (Pubitemid 41278872)
69. Entomological and epidemiological investigations of malaria transmission in relation to population movements in forest areas of north-west Thailand. Somboon P, Aramrattana A, Lines J, Webber R, Southeast Asian J Trop Med Public Health 1998 29 3 9 9740259 (Pubitemid 128528925)
70. Population movement, socio-economic behavior and the transmission of malaria in northern Thailand. Singhanetra-Renard A, Southeast Asian J Trop Med Public Health 1986 17 396 405 2951857 (Pubitemid 17231862)
71. Characteristics and malaria prevalence of migrant populations in malaria-endemic areas along the Thai-Cambodian border. Wangroongsarb P, Sudathip P, Satimai W, Southeast Asian J Trop Med Public Health 2012 43 261 269 23082578
72. Genome diversity and applications in genetic studies of the human malaria parasites Plasmodium falciparum and Plasmodium vivax. Pattaradilokrat S, Jiangbing M, Awadalla P, Su XZ, Malaria Parasites: Comparative Genomics, Evolution and Molecular Biology Wymondham: Caister Academic Press, Carlton JM, Perkins SL, Deitsch KW, 2013 59 90
73. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. Blackman MJ, Scott-Finnigan TJ, Shai S, Holder AA, J Exp Med 1994 180 389 393 10.1084/jem.180.1.389 7516416 (Pubitemid 24181090)
74. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1. James S, Moehle K, Renard A, Mueller MS, Vogel D, Zurbriggen R, Pluschke G, Robinson JA, Chembiochem 2006 7 1943 1950 10.1002/cbic.200600357 17068840 (Pubitemid 44893530)
75. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. Pizarro JC, Chitarra V, Verger D, Holm I, Petres S, Dartevelle S, Nato F, Longacre S, Bentley GA, J Mol Biol 2003 328 1091 1103 10.1016/S0022-2836(03)00376-0 12729744 (Pubitemid 36506876)
76. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. Guevara-Patino JA, Holder AA, McBride JS, Blackman MJ, J Exp Med 1997 186 1689 1699 10.1084/jem.186.10.1689 9362529 (Pubitemid 27506282)